Results 191 to 200 of about 10,069,440 (255)

Expanding horizons of intravitreal anti-vascular endothelial growth factor therapy in retinal diseases. [PDF]

Indian J Ophthalmol
Singh S, Kala U, Bamel A, Agarwal M.
europepmc   +1 more source

Potential of Nanoparticle‐Based Phototherapies for Future Treatment of Uveal Melanoma

Advanced Science, EarlyView.
This review evaluates nanoparticle‐based phototherapies for uveal melanoma, highlighting emerging strategies to enhance tumor targeting, light delivery, and treatment precision. Preclinical data indicate improved efficacy and reduced toxicity, supporting their potential to enhance localized treatment and future translational advances. (Generated by the
Emilie Lambert, Christophe Nguyen, Sean Edward Dunn, Magali Gary‐Bobo, Jérôme Lacombe, Justin Moser, Frédéric Zenhausern, Jean‐Olivier Durand, Frédérique Cunin   +8 more
wiley   +1 more source

Levels of vascular endothelial growth factor and filtration surgery outcomes in diabetic patients with acute primary angle closure. [PDF]

Front Med (Lausanne)
Qian T, Fu M, Zhou H, Zhang Z, Hu Y.
europepmc   +1 more source

Uhrf1‐Mediated PKM2 Degradation via Ubiquitination Alleviates Inflammation and Pyroptosis in Inflammatory Bowel Disease

Advanced Science, EarlyView.
Uhrf1‐mediated PKM2 ubiquitination and degradation repressed the nuclear translocation of PKM2, and EPT served as a molecular glue capable of targeting the Uhrf1–PKM2 complex to alleviate the IBD course, suggesting that the Uhrf1–PKM2 axis was a previously unrecognized strategy for treating IBD.
Juan Zhang, Xin‐Rong Xu, Hui‐Lin Zhang, Qi‐Meng Zhu, Xin‐Yuan Li, Xi‐Peng Shang, Jing‐Hui Du, Christophe Morisseau, Feng Qiu, Cheng‐Peng Sun   +9 more
wiley   +1 more source

MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors. [PDF]

Bone Rep
Mammone G, Coropciuc R, Van den Wyngaert T, Jacobs R, Bossier P, Kerkhofs C, Wijnen L, Meerschaert S, Vissenaekens E, Clement PM, Bechter O, Debruyne PR, Laenen A, Beuselinck B.   +13 more
europepmc   +1 more source

Mesenchymal Stromal Cell‐Based Cell–Drug Conjugates for the Treatment of Acute Liver Failure

Advanced Science, EarlyView.
Mesenchymal stromal cell (MSC)‐based cell‐drug conjugates are constructed by anchoring rosiglitazone‐loaded nanoparticles onto the MSC surface. Sustained rosiglitazone release enhances MSC proliferation and paracrine activity while promoting anti‐inflammatory macrophage polarization.
Tenghui Ye, Jiamin Wu, Zixin Wu, Xi Liu, Jiajia Luo, Leyi Yang, Peng Shi   +6 more
wiley   +1 more source

Diabetic retinopathy and vascular endothelial growth factor

Journal of Research in Medical Sciences, 2013
Majid Khazaei
doaj  

Structural and Molecular Adaptations of the Placenta of Gestational Diabetes Mellitus Patients: Impact of Treatment on Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor Receptor 1, and Insulin-Like Growth Factor Expression. [PDF]

Cureus
Jois S, Lokanathan TH, H T G, Dhananjaya SY.   +3 more
europepmc   +1 more source